Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds
Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17.
Monday, November 1, 2021
Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds
Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds
Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17.
Related Posts:
Wall Street opens lower as trade fears weigh- U.S. rate-rigging payouts top $500 million as final banks settle
- U.S. top court rejects Nomura and RBS appeal in mortgage-backed securities case
- Advent says to acquire GE's distributed power business for $3.25 billion
- Amazon takes Whole Foods' discounts nationwide
0 comments:
Post a Comment